The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125399885 12539988 5 F 2008 20160926 20160708 20160930 PER US-GLAXOSMITHKLINE-US2016090888 GLAXOSMITHKLINE 0.00 F Y 0.00000 20160930 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125399885 12539988 1 PS VENTOLIN HFA ALBUTEROL SULFATE 1 UNK U 5ZP9544 20983
125399885 12539988 2 SS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 R759215 0 INHALATION POWDER
125399885 12539988 3 SS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 UNK 0 INHALATION POWDER

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125399885 12539988 1 Asthma
125399885 12539988 2 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125399885 12539988 Anxiety
125399885 12539988 Arthralgia
125399885 12539988 Back pain
125399885 12539988 Bronchitis
125399885 12539988 Cough
125399885 12539988 Dizziness
125399885 12539988 Drug ineffective
125399885 12539988 Dysgeusia
125399885 12539988 Dysphonia
125399885 12539988 Emotional disorder
125399885 12539988 Fatigue
125399885 12539988 Fungal infection
125399885 12539988 Headache
125399885 12539988 Hyperphagia
125399885 12539988 Ill-defined disorder
125399885 12539988 Increased appetite
125399885 12539988 Insomnia
125399885 12539988 Mania
125399885 12539988 Muscle spasms
125399885 12539988 Nasopharyngitis
125399885 12539988 Sleep apnoea syndrome
125399885 12539988 Sneezing
125399885 12539988 Throat irritation
125399885 12539988 Vaginal discharge
125399885 12539988 Vertigo
125399885 12539988 Vulvovaginal mycotic infection
125399885 12539988 Vulvovaginal pruritus

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125399885 12539988 1 2006 0
125399885 12539988 3 20160806 20160811 0